Foran Intersects 8.3 Metres of 12.5% Zinc Equivalent at McIlvenna Bay
01 nov. 2018 07h00 HE
|
Foran Mining Corporation
VANCOUVER, British Columbia, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Foran Mining Corporation (TSX.V: FOM) (“Foran” or the “Company”) is pleased to announce a summary of results from six additional holes...
First Financial Northwest, Inc. Reports Third Quarter Net Income of $2.8 Million or $0.27 per Diluted Share
25 oct. 2018 09h15 HE
|
First Financial Northwest, Inc.
RENTON, Wash., Oct. 25, 2018 (GLOBE NEWSWIRE) -- First Financial Northwest, Inc. (the “Company”) (NASDAQ GS: FFNW), the holding company for First Financial Northwest Bank (the “Bank”), today...
Osisko Gold Royalties Provides Notice of Third Quarter 2018 Financial Results Release and Conference Call
18 oct. 2018 08h30 HE
|
Osisko Gold Royalties Ltd.
MONTREAL, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Corporation” or “Osisko”) (TSX & NYSE:OR) announces that its third quarter 2018 financial results will be released...
ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
09 oct. 2018 16h15 HE
|
ObsEva SA
Abstract featuring-IMPLANT2 data awarded Prize Paper by Society for Assisted Reproductive Technology (SART) Nolasiban treatment shown to significantly increase Live Birth Rate (LBR) in...
ObsEva SA Announces Phase 3 IMPLANT 2 Clinical Trial Results of Nolasiban in IVF to be Presented at Annual ASRM Meeting Tuesday October 9, 2018
05 oct. 2018 01h00 HE
|
ObsEva SA
Recipient of Prize Paper Award from the Society for Assisted Reproductive Technology (SART) Geneva, Switzerland and Boston, MA - October 5, 2018- ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a...
Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for the treatment of endometriosis-associated pain
28 sept. 2018 01h00 HE
|
ObsEva SA
Linzagolix overall efficacy and safety maintained or improved at week 24 Linzagolix 75mg once daily showed no clinically significant impact on Bone Mineral Density (BMD), supporting further...
Nexeo Solutions Reports Third Quarter Fiscal Year 2018 Financial Results
06 août 2018 16h20 HE
|
Nexeo Solutions, Inc.
Third Quarter 2018 Highlights (Versus Third Quarter 2017) Revenue growth of 11%, driven by strong price execution, specialty growth and an improved market environmentNet income for the quarter was...
GrowLife, Inc. Reports Over 131% Year-Over-Year Revenue Growth in Second Quarter 2018 Financial Results and Operational Ramp-Up Highlights Update
02 août 2018 08h55 HE
|
GrowLife, Inc.
KIRKLAND, Wash., Aug. 02, 2018 (GLOBE NEWSWIRE) -- GrowLife, Inc. (OTCQB: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers,...
Shell Midstream Partners, L.P. 2nd Quarter 2018 Unaudited Results
02 août 2018 08h30 HE
|
Shell Midstream Partners LP
Houston, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Shell Midstream Partners, L.P. (NYSE: SHLX), a growth-oriented midstream master limited partnership formed by Royal Dutch Shell plc (“RDS”), reported net...
Teranga Gold Reports Record Q2 and H1 Production, Raises 2018 Guidance
02 août 2018 06h00 HE
|
Teranga Gold Corporation
(All amounts are in U.S. dollars unless otherwise stated) TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Teranga Gold Corporation ("Teranga" or the "Company") (TSX:TGZ; OTCQX:TGCDF) today reported its...